BioCentury
ARTICLE | Company News

Valeant Pharmaceuticals, Sanitas Group deal

August 29, 2011 7:00 AM UTC

Valeant completed its acquisition of Lithuanian branded generics company Sanitas for about €314 million ($452.4 million) in cash (see BioCentury, May 30). ...